- Home
- ALLO vs NPV Comparison
ALLO vs NPV Comparison
Compare ALLO & NPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLO
- NPV
- Stock Information
- Founded
- ALLO 2017
- NPV 1993
- Country
- ALLO United States
- NPV United States
- Employees
- ALLO N/A
- NPV N/A
- Industry
- ALLO Biotechnology: Biological Products (No Diagnostic Substances)
- NPV Investment Managers
- Sector
- ALLO Health Care
- NPV Finance
- Exchange
- ALLO Nasdaq
- NPV Nasdaq
- Market Cap
- ALLO 252.9M
- NPV 208.1M
- IPO Year
- ALLO 2018
- NPV N/A
- Fundamental
- Price
- ALLO $1.27
- NPV $11.24
- Analyst Decision
- ALLO Buy
- NPV
- Analyst Count
- ALLO 11
- NPV 0
- Target Price
- ALLO $8.67
- NPV N/A
- AVG Volume (30 Days)
- ALLO 2.3M
- NPV 38.9K
- Earning Date
- ALLO 11-06-2025
- NPV 01-01-0001
- Dividend Yield
- ALLO N/A
- NPV 3.90%
- EPS Growth
- ALLO N/A
- NPV N/A
- EPS
- ALLO N/A
- NPV N/A
- Revenue
- ALLO N/A
- NPV N/A
- Revenue This Year
- ALLO N/A
- NPV N/A
- Revenue Next Year
- ALLO $100.00
- NPV N/A
- P/E Ratio
- ALLO N/A
- NPV N/A
- Revenue Growth
- ALLO N/A
- NPV N/A
- 52 Week Low
- ALLO $0.86
- NPV $8.92
- 52 Week High
- ALLO $3.78
- NPV $11.55
- Technical
- Relative Strength Index (RSI)
- ALLO 53.43
- NPV 33.71
- Support Level
- ALLO $1.16
- NPV $11.32
- Resistance Level
- ALLO $1.28
- NPV $11.48
- Average True Range (ATR)
- ALLO 0.09
- NPV 0.11
- MACD
- ALLO 0.01
- NPV -0.03
- Stochastic Oscillator
- ALLO 70.68
- NPV 2.71
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
About NPV Nuveen Virginia Quality Municipal Income Fund
Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities. Company mostly invest in Education and Civic Organizations, Tax Obligation/General, Healthcare, Utilities , Housing/Multifamily, Transportation, and Others.